{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-020489","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.331820+00:00","generated_at":"2026-06-01T18:08:48.017153+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Enveric Biosciences receives Nasdaq delisting notice for bid price below $1.00","bullets":["Closing bid price below $1.00 for 30 consecutive business days as of May 16, 2024.","Company has 180 days, until November 12, 2024, to regain compliance by closing at or above $1.00 for 10 consecutive days.","If not compliant by deadline, may be eligible for additional 180 days if other listing standards met.","Company considering available options, including potential reverse stock split, to cure deficiency.","Failure to regain compliance could result in delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-020489","json":"https://secwatch.observer/filing/0001493152-24-020489.json","markdown":"https://secwatch.observer/filing/0001493152-24-020489.md","text":"https://secwatch.observer/filing/0001493152-24-020489.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315224020489/0001493152-24-020489-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315224020489/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T18:08:48.017153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"657665681841436ab2a3202ef816b5a7480008b4","claim":"Enveric Biosciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"May 16, 2024, Enveric Biosciences, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The notificat","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315224020489/0001493152-24-020489-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}